HMGCR and ovarian carcinoma: Statins (HMGCR blockers), lonafarnib (farnesyltransferase inhibitors), the anti-inflammatory drug aspirin, and the anti-malarial drug adiponectin all have a therapeutic role in ovarian cancer.